IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting

Clinical trial NCT02967289 · COMPLETED

Trial details

NCT number: NCT02967289
Sponsor: UNICANCER
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Colon Cancer (High-risk Stage III: pT4N1 or pT1 to 4 N2)

Start date: 2017-03-27
Primary completion: 2025-06-15
Enrollment: 792

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.